Sebastian Schulz

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Immunology, Virology, Viral Structural Protein +3

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch et al. · European Journal of Immunology · 2019 · 965 citations · Full text

Laboratory Immunology, Immunology, Pathology +18

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann, Nadine Krüger, Sebastian Schulz et al. · Cell · 2021 · 945 citations · Full text

Covid-19 Pandemic, Immunology, Antibody-mediated Neutralization +9

Observational Study Mortality in Treated Primary Aldosteronism

Martín Reincke, Evelyn Fischer, S. Gerum et al. · Hypertension · 2012 · 265 citations · Full text

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger et al. · Cell Reports · 2021 · 238 citations · Full text

Vaccination, Viral Evolution, Spike Protein +15